RETA Analysis

Reata Pharmaceuticals, Inc.
Stock Exchange: NASDAQ
Sector: healthcare
32.87
Last session price
32.87
Price now
Currency: USD
Reporting currency: USD
ISIN: US75615P1030
INN:
.

RETA financial statements

* Numbers in millions
Capitalization * 1 190
EV * 2 933
Number of shares * 36
EPS -6,84
Revenue * 9
Net income * -248
Operating profit * -226
Total liabilities * 440
Net debt * -818
Total assets * 858
Equity * 417
Cash and investments * 818
.

RETA valuation

P/E -4,80
P/B 2,85
P/S 131,95
E/P -21
P/FCF -3,68
.

RETA profitability

ROE -59%
ROA% -29%
ROIC% -31%